ENDPOINTS

AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data

Plus, news about the Novo Nordisk Foundation and Tonix: AbbVie’s Rinvoq gets label expansion: The blockbuster JAK inhibitor won approval in the US to treat adults with giant cell arteritis, an ...

Apr 29, 2025 - 15:20
 0
AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data
Plus, news about the Novo Nordisk Foundation and Tonix: AbbVie’s Rinvoq gets label expansion: The blockbuster JAK inhibitor won approval in the US to treat adults with giant cell arteritis, an ...
Read More

Tags:

Previous Article

What’s really broken with supply chain security is the demand chain

Next Article

Get a full-sized wooden swing set for $209 delivered during Wayfair’s extended W...

Related Posts

Cassidy urges major reforms to 340B drug discount program

Cassidy urges major reforms to 340B drug discount program

Apr 24, 2025  0

Alvogen unit appeals court loss in bid to market Xifaxan generic

Alvogen unit appeals court loss in bid to market Xifaxa...

Apr 21, 2025  0

Merck is well-stocked on Keytruda as pharma tariffs loom, CEO says

Merck is well-stocked on Keytruda as pharma tariffs loo...

Apr 24, 2025  0